Comparison between hemodynamic effects of remimazolam and propofol during general anesthesia: a systematic review and meta-analysis.
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The need for safe anesthetic agents with minimal side effects has led to the development of remimazolam, a new benzodiazepine designed to be an alternative to the commonly used drug propofol, which has significant hemodynamic effects. This study aims to compare the hemodynamic effects of remimazolam with propofol during general anesthesia. EVIDENCE ACQUISITION: A systematic search was conducted in Embase, Web of Science, Cochrane Library, Scopus, and PubMed databases on 13/02/2023, following the recommendations of Cochrane Handbook and the PRISMA statement. The measure of association used was Risk Ratio (RR) or standardized mean difference, with 95% confidence intervals (CI) and 95% Prediction intervals (PI). An additional search was conducted on 04/09/2023. A Trial Sequential Analysis and a GRADE (Grading of Recommendations Assessment, Development and Evaluation) evidence table were conducted based on the editor's recommendation. EVIDENCE SYNTHESIS: After applying eligibility criteria and removing duplicates, 16 randomized clinical trials comprising 1951 patients were included in the meta-analysis. Significant associations favoring remimazolam over propofol were observed in the following aspects: intraoperative hypotension events (RR=0.47; 95% CI=0.41 to 0.54; 95% PI=0.40 to 0.55); frequency of vasoactive drug administration (RR=0.54; 95% CI=0.46 to 0.64; 95% PI=0.41 to 0.74); intraoperative bradycardia (RR=0.39; 95% CI=0.27 to 0.57; 95% PI=0.26 to 0.66); mean arterial pressure at induction (MD=7.77; 95% CI=6.00 to 9.55; 95% PI=4.39 to 11.15); heart rate at induction (MD=6.40; 95% CI=4.07 to 8.73; 95% PI=0.33 to 12.48); and heart rate at intubation (MD=6.06; 95% CI=2.33 to 9.78; 95% PI=-5.59 to 17.71). CONCLUSIONS: This study provides evidence that remimazolam induces fewer cardiorespiratory depressant effects and has a more favorable side effect profile compared to propofol during general anaesthesia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Salmasi, V., Maheshwari, K., Yang, D., Mascha, E. J., Singh, A., Sessler, D. I., & Kurz, A. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001432 · Cited by 1,104
Clinical pharmacokinetics and pharmacodynamics of propofol
Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0672-3 · Cited by 809
The Autonomic Nervous System and Hypertension
Mancia, G., & Grassi, G. (2014) · Circulation Research · doi:10.1161/circresaha.114.302524 · Cited by 627
Doi, M., Morita, K., Takeda, J., Sakamoto, A., Yamakage, M., & Suzuki, T. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02788-6 · Cited by 484
Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent
Kilpatrick, G. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690875 · Cited by 262
Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment
Stöhr, T., Colin, P. J., Ossig, J., Pesic, M., Borkett, K., Winkle, P., Struys, M. M. R. F., & Schippers, F. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.05.027 · Cited by 207
Choi, J. Y., Lee, H. S., Kim, J. Y., Han, D. W., Yang, J. Y., Kim, M. J., & Song, Y. (2022) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2022.110955 · Cited by 133
Mao, Y., Guo, J., Yuan, J., Zhao, E., & Yang, J. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s359496 · Cited by 122
Cited by
Shi, P., Wang, C., Tang, Y., Hou, J., Bian, J., & Bo, L. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s564187 · Cited by 9
“Detailed hemodynamic data are provided in Figure 3.”
Model-Informed Precision Dosing of Remimazolam in General Anesthesia Patients
Chen, Y., Zhang, Z.-J., Zhang, X.-F., Peng, Y., Jiao, Z., & Wu, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s495604 · Cited by 6
“1,2 It has a certain advantage in clinical anesthesia applications.”
Shon, H.-S., Kim, H. Y., Yoon, J.-U., et al. (2025) · Korean Journal of Anesthesiology · doi:10.4097/kja.25376 · Cited by 2
Osawa, R., Uchida, R., & Asai, T. (2026) · Journal of Anesthesia · doi:10.1007/s00540-026-03841-6 · Cited by 2
Cao, C., Pan, C., Zhu, W.-J., & Xue, F. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0583 · Cited by 1
Metadata
- Authors
- WEGNER, B. M., WEGNER, G. M., SPAGNOL, L. W., COSTA, L. A., SPAGNOL, V. W., & PAIVA, D. F.
- Affiliations
- Universidade Federal da Fronteira Sul (BR)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Corresponding author
- SPAGNOL, Valentine W.
- Venue
- Minerva Anestesiologica
- Publisher
- Edizioni Minerva Medica
- Published
- 2024-10
- Volume
- 90
- Issue
- 10
- Pages
- 901-911
- ISSN
- 0375-9393 (ISSN-L)
- 1827-1596
- OpenAlex
- W4401339373
- Cited by
- 19
- References
- 31
- Citations by year
- 2026: 10 · 2025: 6 · 2024: 2
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Minerva Anestesiologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
- Keywords
- remimazolam, propofol, general anesthesia, hemodynamic effects, intraoperative hypotension, intraoperative bradycardia, mean arterial pressure, heart rate, intubation, benzodiazepines, anesthetic comparison, trial sequential analysis, risk of bias, heterogeneity, publication bias
- MeSH terms
- Anesthesia, General, Benzodiazepines, Hemodynamics, Humans, Propofol, Anesthetics, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison between hemodynamic effects of remimazolam and propofol during general anesthesia: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.23736/s0375-9393.24.18041-8
- The paper
- WEGNER, B. M., WEGNER, G. M., SPAGNOL, L. W., COSTA, L. A., SPAGNOL, V. W., & PAIVA, D. F. (2024). Comparison between hemodynamic effects of remimazolam and propofol during general anesthesia: a systematic review and meta-analysis. Minerva Anestesiologica. https://doi.org/10.23736/s0375-9393.24.18041-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.